p.93 抽出テキスト

397. Mathieu P, Poirier P, Pibarot P, Lemieux I, Després JP. Visceral obesity: the link among inflammation, hypertension, and cardiovascular disease. Hypertension 2009;53:577–84. https://doi.org/10.1161/hypertensionaha.108.110320 398. Chandra A, Neeland IJ, Berry JD, Ayers CR, Rohatgi A, Das SR, et al. The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas heart study. J Am Coll Cardiol 2014;64:997–1002. https://doi.org/10.1016/j.jacc. 2014.05.057 399. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003;42: 878–84. https://doi.org/10.1161/01.Hyp.0000094221.86888.Ae 400. Haase CL, Lopes S, Olsen AH, Satylganova A, Schnecke V, McEwan P. Weight loss and risk reduction of obesity-related outcomes in 0.5 million people: evidence from a UK primary care database. Int J Obes (Lond) 2021;45:1249–58. https://doi.org/10.1038/ s41366-021-00788-4 401. Moore LL, Visioni AJ, Qureshi MM, Bradlee ML, Ellison RC, D’Agostino R. Weight loss in overweight adults and the long-term risk of hypertension: the Framingham study. Arch Intern Med 2005;165:1298–303. https://doi.org/10.1001/archinte.165.11.1298 402. Zomer E, Gurusamy K, Leach R, Trimmer C, Lobstein T, Morris S, et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 2016;17:1001–11. https://doi.org/10.1111/obr.12433 403. Wing RR, Espeland MA, Clark JM, Hazuda HP, Knowler WC, Pownall HJ, et al. Association of weight loss maintenance and weight regain on 4-year changes in CVD risk factors: the action for health in diabetes (Look AHEAD) clinical trial. Diabetes Care 2016;39:1345–55. https://doi.org/10.2337/dc16-0509 404. Ma C, Avenell A, Bolland M, Hudson J, Stewart F, Robertson C, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 2017;359:j4849. https://doi.org/10. 1136/bmj.j4849 405. Semlitsch T, Krenn C, Jeitler K, Berghold A, Horvath K, Siebenhofer A. Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev 2021;2:CD008274. https://doi.org/10.1002/14651858.CD008274.pub4 406. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369: 145–54. https://doi.org/10.1056/NEJMoa1212914 407. Pagidipati NJ, Phelan M, Page C, Clowse M, Henao R, Peterson ED, et al. The importance of weight stabilization amongst those with overweight or obesity: results from a large health care system. Prev Med Rep 2021;24:101615. https://doi.org/10.1016/j. pmedr.2021.101615 408. Estruch R, Ros E, Salas-Salvadó J, Covas M-I, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 2018;378:e34. https://doi.org/10.1056/NEJMoa1800389 409. Delgado-Lista J, Alcala-Diaz JF, Torres-Peña JD, Quintana-Navarro GM, Fuentes F, Garcia-Rios A, et al. Long-term secondary prevention of cardiovascular disease with a Mediterranean diet and a low-fat diet (CORDIOPREV): a randomised controlled trial. Lancet 2022;399:1876–85. https://doi.org/10.1016/s0140-6736(22)00122-2 410. Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin P-H, et al. Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010;170:126–35. https://doi.org/10. 1001/archinternmed.2009.470 411. Juraschek SP, Miller ER III, Weaver CM, Appel LJ. Effects of sodium reduction and the DASH diet in relation to baseline blood pressure. J Am Coll Cardiol 2017;70:2841–8. https://doi.org/10.1016/j.jacc.2017.10.011 412. Gay HC, Rao SG, Vaccarino V, Ali MK. Effects of different dietary interventions on blood pressure: systematic review and meta-analysis of randomized controlled trials. Hypertension 2016;67:733–9. https://doi.org/10.1161/hypertensionaha.115.06853 413. Siebenhofer A, Winterholer S, Jeitler K, Horvath K, Berghold A, Krenn C, et al. Long-term effects of weight-reducing drugs in people with hypertension. Cochrane Database Syst Rev 2021;1:CD007654. https://doi.org/10.1002/14651858. CD007654.pub5 414. Müller TD, Blüher M, Tschöp MH, DiMarchi RD. Anti-obesity drug discovery: advances and challenges. Nat Rev Drug Discov 2022;21:201–23. https://doi.org/10.1038/s41573- 021-00337-8 415. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med 2021; 384:989–1002. https://doi.org/10.1056/NEJMoa2032183 416. Davies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebocontrolled, phase 3 trial. Lancet 2021;397:971–84. https://doi.org/10.1016/ s0140-6736(21)00213-0 417. Tasnim S, Tang C, Musini VM, Wright JM. Effect of alcohol on blood pressure. Cochrane Database Syst Rev 2020;7:CD012787. https://doi.org/10.1002/14651858. CD012787.pub2 418. Liu F, Liu Y, Sun X, Yin Z, Li H, Deng K, et al. Race- and sex-specific association between alcohol consumption and hypertension in 22 cohort studies: a systematic review and meta-analysis. Nutr Metab Cardiovasc Dis 2020;30:1249–59. https://doi. org/10.1016/j.numecd.2020.03.018 419. Griswold MG, Fullman N, Hawley C, Arian N, Zimsen SRM, Tymeson HD, et al. Alcohol use and burden for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet 2018;392:1015–35. https://doi.org/10.1016/s0140-6736(18)31310-2 420. D’Elia L, La Fata E, Galletti F, Scalfi L, Strazzullo P. Coffee consumption and risk of hypertension: a dose–response meta-analysis of prospective studies. Eur J Nutr 2019;58:271–80. https://doi.org/10.1007/s00394-017-1591-z 421. Hodgson JM, Puddey IB, Woodman RJ, Mulder TPJ, Fuchs D, Scott K, et al. Effects of black tea on blood pressure: a randomized controlled trial. Arch Intern Med 2012;172: 186–8. https://doi.org/10.1001/archinte.172.2.186 422. Shah SA, Chu BW, Lacey CS, Riddock IC, Lee M, Dargush AE. Impact of acute energy drink consumption on blood pressure parameters: a meta-analysis. Ann Pharmacother 2016;50:808–15. https://doi.org/10.1177/1060028016656433 423. Shah SA, Szeto AH, Farewell R, Shek A, Fan D, Quach KN, et al. Impact of high volume energy drink consumption on electrocardiographic and blood pressure parameters: a randomized trial. J Am Heart Assoc 2019;8:e011318. https://doi.org/10. 1161/jaha.118.011318 424. Basrai M, Schweinlin A, Menzel J, Mielke H, Weikert C, Dusemund B, et al. Energy drinks induce acute cardiovascular and metabolic changes pointing to potential risks for young adults: a randomized controlled trial. J Nutr 2019;149:441–50. https://doi. org/10.1093/jn/nxy303 425. Fung TT, Malik V, Rexrode KM, Manson JE, Willett WC, Hu FB. Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr 2009;89: 1037–42. https://doi.org/10.3945/ajcn.2008.27140 426. Mullee A, Romaguera D, Pearson-Stuttard J, Viallon V, Stepien M, Freisling H, et al. Association between soft drink consumption and mortality in 10 European countries. JAMA Intern Med 2019;179:1479–90. https://doi.org/10.1001/jamainternmed. 2019.2478 427. Farhangi MA, Nikniaz L, Khodarahmi M. Sugar-sweetened beverages increases the risk of hypertension among children and adolescence: a systematic review and dose–response meta-analysis. J Transl Med 2020;18:344. https://doi.org/10.1186/s12967-020- 02511-9 428. Critchley JA, Capewell S. Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. JAMA 2003;290:86–97. https://doi.org/10.1001/jama.290.1.86 429. Anthonisen NR, Skeans MA, Wise RA, Manfreda J, Kanner RE, Connett JE. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial. Ann Intern Med 2005;142:233–9. https://doi.org/10.7326/0003-4819-142- 4-200502150-00005 430. Thomson B, Emberson J, Lacey B, Lewington S, Peto R, Jemal A. Association between smoking, smoking cessation, and mortality by race, ethnicity, and sex among US adults. JAMA Netw Open 2022;5:e2231480. https://doi.org/10.1001/jamanetworkopen. 2022.31480 431. Yang JJ, Yu D, Shu XO, Wen W, Rahman S, Abe S. Reduction in total and major causespecific mortality from tobacco smoking cessation: a pooled analysis of 16 populationbased cohort studies in Asia. Int J Epidemiol 2022;50:2070–81. https://doi.org/10.1093/ ije/dyab087 432. Martinez-Morata I, Sanchez TR, Shimbo D, Navas-Acien A. Electronic cigarette use and blood pressure endpoints: a systematic review. Curr Hypertens Rep 2020;23:2. https:// doi.org/10.1007/s11906-020-01119-0 433. Kim SY, Jeong SH, Joo HJ, Park M, Park E-C, Kim JH, et al. High prevalence of hypertension among smokers of conventional and e-cigarette: using the nationally representative community dwelling survey. Front Public Health 2022;10:919585. https://doi.org/ 10.3389/fpubh.2022.919585 434. Groppelli A, Giorgi DM, Omboni S, Parati G, Mancia G. Persistent blood pressure increase induced by heavy smoking. J Hypertens 1992;10:495–9. https://doi.org/10.1097/ 00004872-199205000-00014 435. Primatesta P, Falaschetti E, Gupta S, Marmot MG, Poulter NR. Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 2001;37:187–93. https://doi.org/10.1161/01.hyp.37.2.187 436. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;2013: CD000165. https://doi.org/10.1002/14651858.CD000165.pub4 437. Rasmussen M, Lauridsen SV, Pedersen B, Backer V, Tønnesen H. Intensive versus short face-to-face smoking cessation interventions: a meta-analysis. Eur Respir Rev 2022;31: 220063. https://doi.org/10.1183/16000617.0063-2022 438. Filippou CD, Thomopoulos CG, Kouremeti MM, Sotiropoulou LI, Nihoyannopoulos PI, Tousoulis DM, et al. Mediterranean diet and blood pressure reduction in adults with and without hypertension: a systematic review and meta-analysis of randomized controlled trials. Clin Nutr 2021;40:3191–200. https://doi.org/10.1016/j.clnu.2021.01.030 439. Cowell OR, Mistry N, Deighton K, Matu J, Griffiths A, Minihane AM, et al. Effects of a Mediterranean diet on blood pressure: a systematic review and meta-analysis of randomized controlled trials and observational studies. J Hypertens 2021;39:729–39. https://doi.org/10.1097/hjh.0000000000002667 Downloaded from academic.oup.com/eurheartj/article/45/38/3912/7741010 by guest on 07 October 2026